Assessment of cardiac autonomic nervous system involvement in systemic sclerosis via exercise heart rate recovery

Medical Principles and Practice

Volumn 24, Issue 1, 2015, Pages 17-22

  Karakulak, Ugur Nadir ^a   Okutucu, Sercan ^a   Şahiner, Levent ^a   Maharjan, Naresh ^a   Aladag, Elifcan ^a   Akdogan, Ali ^a   Kilic, Levent ^a   Kaya, Ergun Baris ^a   Aytemir, Kudret ^a   Tokgozoglu, Lale ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cardiac autonomic dysfunction; Heart rate recovery; Scleroderma

Indexed keywords

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MALE; SYSTEMIC SCLEROSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; TREADMILL EXERCISE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CASE CONTROL STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TURKEY;

ADULT; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; STROKE VOLUME; TURKEY;

EID: 84921435030     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000368359     Document Type: Article

References (29)

1. Jimenez SA, Derk CT: Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004; 140: 37-50.
2. LeRoy EC, Black C, Fleischmajer R: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
3. Allanore Y, Meune C, Kahan A: Outcome measures for heart involvement in systemic sclerosis. Rheumatology 2008; 47(suppl 5): v51-v53.
4. Seferovic PM, Ristic AD, Maksimovic R: Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology 2006; 45(suppl 4):39-42.
5. Vachiery JL, Coghlan G: Screening for pulmonary arterial hypertension in systemic sclerosis. Eur Respir Rev 2009; 18: 162-169.
6. Kepez A, Akdogan A, Sade LE, et al: Detection of subclinical cardiac involvement in systemic sclerosis by echocardiographic strain imaging. Echocardiography 2008; 25: 191-197.
7. Kahan A, Allanore Y: Primary myocardial involvement in systemic sclerosis. Rheumatology 2006; 45(suppl 4):14-17.
8. Medsger TA Jr, Masi AT: Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male US veteran patients. J Chronic Dis 1973; 26: 647-660.
9. Okutucu S, Kabakci G, Deveci OS, et al: Relationship between exercise heart rate recovery and circadian blood pressure pattern. J Clin Hypertens 2010; 12: 407-413.
10. Gibbons RJ: Abnormal heart-rate recovery after exercise. Lancet 2002; 359: 1536-1537.
11. Morshedi-Meibodi A, Larson MG, Levy D, et al: Heart rate recovery after treadmill exercise testing and risk of cardiovascular disease events (the Framingham heart study). Am J Cardiol 2002; 90: 848-852.
12. Cole CR, Blackstone EH, Pashkow FJ, et al: Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999; 341: 1351-1357.
13. Klimiuk PS, Taylor L, Baker RD, et al: Autonomic neuropathy in systemic sclerosis. Ann Rheum Dis 1988; 47: 542-545.
14. Morelli S, Piccirillo G, Fimognari F, et al: Twenty-four hour heart period variability in systemic sclerosis. J Rheumatol 1996; 23: 643-645.
15. Ferri C, Emdin M, Giuggioli D, et al: Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rheumatol 1997; 36: 669-676.
16. Bienias P, Ciurzynski M, Glinska-Wielochowska M, et al: Heart rate turbulence assessment in systemic sclerosis: the role for the detection of cardiac autonomic nervous system dysfunction. Rheumatology 2010; 49: 355-360.
17. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
18. Furst DE: Rational therapy in the treatment of systemic sclerosis. Curr Opin Rheumatol 2000; 12: 540-544.
19. Papouchado M, Walker PR, James MA, et al: Fundamental differences between the standard 12-lead electrocardiograph and the modified (Mason-Likar) exercise lead system. Eur Heart J 1987; 8: 725-733.
20. Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
21. Nagueh SF, Appleton CP, Gillebert TC, et al: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-133.
22. Kaya EB, Okutucu S, Aksoy H, et al: Evaluation of cardiac autonomic functions in patients with ankylosing spondylitis via heart rate recovery and heart rate variability. Clin Res Cardiol 2010; 99: 803-808.
23. Vivekananthan DP, Blackstone EH, Pothier CE, et al: Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol 2003; 42: 831-838.
24. Arena R, Guazzi M, Myers J, et al: Prognostic value of heart rate recovery in patients with heart failure. Am Heart J 2006; 151: 851.e7-e13.
25. Okutucu S, Oto A: Risk stratification in nonischemic dilated cardiomyopathy: current perspectives. Cardiol J 2010; 17: 219-229.
26. Sarli B, Dogan Y, Baktir AO, et al: Heart rate recovery is impaired in patients with psoriasis. Med Princ Pract 2013; 22: 567-570.
27. Ciftci O, Onat AM, Yavuz B, et al: Cardiac repolarization abnormalities and increased sympathetic activity in scleroderma. J Natl Med Assoc 2007; 99: 232-237.
28. Pancera P, Sansone S, Presciuttini B, et al: Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon. Clin Sci 1999; 96: 49-57.
29. de Oliveira NC, dos Santos Sabbag LM, Ueno LM, et al: Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement. Scand J Rheumatol 2007; 36: 458-461.